Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is a commercialization stage company focused in the immunotherapy arena, with world-leading technology in Keyhole Limpet Hemocyanin (KLH) protein. KLH is an important immune-stimulating molecule widely used as a key active ingredient in many new immunotherapies, and as an injectable product to assess immune response. Stellar Biotechnologies are committed to applying its Stellar KLH™ platform to power the growing field of disease-targeting immune therapies. For more information, visit the company’s website at www.stellarbiotechnologies.com